PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.80%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
25.99%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
-1760.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-123.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
4.11%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while VALMT.HE is at 21.91%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
100.00%
FCF growth above 1.5x VALMT.HE's 30.41%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-14.93%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 71.76%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
7.18%
5Y revenue/share CAGR under 50% of VALMT.HE's 17.09%. Michael Burry would suspect a significant competitive gap or product weakness.
-16.09%
Negative 3Y CAGR while VALMT.HE stands at 0.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 983.03%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while VALMT.HE is at 1.84%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 826.84%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-122.22%
Negative 10Y net income/share CAGR while VALMT.HE is at 520.56%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-133.33%
Negative 5Y net income/share CAGR while VALMT.HE is 65.09%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-106.42%
Negative 3Y CAGR while VALMT.HE is 10.01%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
76.98%
10Y equity/share CAGR at 50-75% of VALMT.HE's 149.62%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
41.98%
Below 50% of VALMT.HE's 95.70%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.66%
Below 50% of VALMT.HE's 57.49%. Michael Burry suspects a serious short-term disadvantage in building book value.
-41.67%
Cut dividends over 10 years while VALMT.HE stands at 172.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-82.93%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while VALMT.HE stands at 2.55%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.06%
Asset growth above 1.5x VALMT.HE's 0.48%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
68.69%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.